SCHEMBL6323329

SCHEMBL6323329

CCOC(=O)c1ccc(NC(=O)Nc2nnc(-c3cc(F)c(F)c(F)c3O)s2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.54
MEN1 O00255 5/20 0.54
KMT2A Q03164 5/20 0.54
TRPV1 Q8NER1 2/20 0.54
CASP3 P42574 1/20 0.54
SENP7 Q9BQF6 1/20 0.54
NPC1 O15118 6/20 0.53
RAB9A P51151 6/20 0.53
SMN1; SMN2 Q16637 3/20 0.48
HPGD P15428 1/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
GAA P10253 1/20 0.47
NAMPT P43490 1/20 0.46
BLM P54132 1/20 0.45
MAPK1 P28482 2/20 0.44
ALDH1A1 P00352 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
USP2 O75604 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6322386 0.84 TRPV1 (0.53) MAPTMEN1KMT2ATRPV1CASP3
SCHEMBL6325807 0.82 TRPV1 (0.51) MAPTMEN1KMT2ATRPV1CASP3
SCHEMBL6324443 0.82 MAPT (0.54) MAPTMEN1KMT2ATRPV1CASP3
SCHEMBL6325064 0.80 MAPT (0.55) MAPTMEN1KMT2ATRPV1CASP3
SCHEMBL6324484 0.80 KMT2A (0.47) MAPTMEN1KMT2ATRPV1CASP3
SCHEMBL6324633 0.80 RAB9A (0.56) MAPTMEN1KMT2ATRPV1CASP3
SCHEMBL6322762 0.77 MEN1 (0.48) MAPTMEN1KMT2ATRPV1CASP3
SCHEMBL24233043 0.77 KMT2A (0.71) MAPTMEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL6324672 0.74 MAPT (0.53) MAPTMEN1KMT2ATRPV1CASP3
SCHEMBL6323902 0.74 TRPV1 (0.41) MAPTMEN1KMT2ATRPV1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050124664-A1 Urea thiadiazole inhibitors of plasminogen activator inhibior-1 BRISTOL-MYERS SQUIBB CO. 2005-06-09 US claimed
US-20050124664-A1 Urea thiadiazole inhibitors of plasminogen activator inhibior-1 BRISTOL-MYERS SQUIBB CO. 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124664-A1 Urea thiadiazole inhibitors of plasminogen activator inhibior-1 SERPINE1, SERPINC1, SERPINB1 MAPT 3022/4885MEN1 1004/4885KMT2A 4128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.